Bio-innova Co., Ltd

Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®

Role: lead

Sildenafil 100 mg Tablets Relative to Viagra 100 mg Tablets

Role: lead

Nebivolol Tablets 5 mg Relative to Nebilet Tablets 5 mg

Role: lead

Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets

Role: lead

Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets

Role: lead

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator

Role: lead

Ticagrelor Tablets 90 mg Relative to Originator Ticagrelor Tablets 90 mg

Role: lead

Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fed Condition

Role: lead

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Relative to Originator

Role: lead

Dapagliflozin Tablet 10 mg Relative to Forxiga® Tablets 10 mg

Role: lead

Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition

Role: lead

Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets

Role: lead

Desogestrel Tablets (0.075 mg) Relative to Originator Desogestrel Tablets (0.075 mg)

Role: lead

Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®

Role: lead

Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule

Role: lead

Empagliflozin 10 mg Tablets Relative to Jardiance 10 mg

Role: lead